CORONA Remedies

quarterly
yearly
ParticularsSep '24Jun '25Sep '25
Revenue316.33348.56363.40
Expenses258.97287.67293.79
EBITDA69.2871.8080.74
EBIT60.2262.6871.71
Profit Before Tax57.3560.6969.78
Net Profit42.9746.2052.32
Financial Ratios
Operating Profit Margin22.07%20.66%22.40%
Net Profit Margin13.69%13.33%14.49%
Earning Per Share (Diluted)7.037.558.55
Dividends Per Share0.000.000.00